MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajh/hpag047

Медицинская библиотека · American journal of hypertension · 2026

Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.

Hüttl Veronica N, Deutz Nicolaas E P, Wierzchowska-McNew Raven A, Ruebush Laura E, Engelen Mariëlle P K J

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Arginine, as precursor of the antihypertensive metabolite nitric oxide, may influence blood pressure (BP) regulation and is therefore linked to hypertension, a serious global health issue. Thus, we investigated whether hypertension relates to alterations in arginine metabolism and examined the role of biological sex and body composition.

METHODS

We stratified 762 older adults (50-95 years old) participating in the MEDIT-trial into 4 BP groups (normal, elevated, stage 1 and 2 hypertension) per 2025 ACC/AHA guidelines. Body composition was assessed by dual-energy X-ray absorptiometry. After administering stable tracers of arginine, citrulline, and ornithine, blood samples were taken to measure postabsorptive plasma amino acid concentrations and tracer enrichments by LC-MS/MS. Compartmental modeling was applied to determine amino acid kinetics.

RESULTS

Age and glucose, hs-CRP, and arginine levels were comparable across groups. Older adults with stage 1 and stage 2 hypertension had higher BMIs than those with normal BP (29.7 kg/m2 and 31.0 kg/m2 vs. 27.8 kg/m2). Whole-body and intracellular arginine production in stage 2 hypertension were increased by 10.4% and 10.7% compared to those with normotension (all: P < .05), particularly in females (whole-body: +13.7%; intracellular: +18.3%; all: P < .02). While females showed progressive increases in body composition parameters along BP groups, males displayed relatively stable values.

CONCLUSIONS

Arginine metabolism in older adults is influenced by hypertension severity, with sex-specific differences in metabolic adaptation. Further research is warranted determining whether hypertension treatment for older adults should be individualized to disease severity, accounting for the upregulated arginine metabolism and sex-specific differences, which may lead to improved outcomes.

CLINICAL TRIAL REGISTRATION: www.clinicalTrials.gov, Trial Numbers: NCT01787682, NCT01871350, NCT01624792, NCT01890824, NCT02082418, NCT02157844, NCT06801964, NCT02065141, NCT03159390, NCT02770092, NCT02908425, NCT02780219, NCT02780206, NCT03327181, NCT06801951, NCT03796455, NCT04928872, NCT04461236, NCT05395390, NCT05240885, NCT06628349.

Для цитирования: Hüttl Veronica N, Deutz Nicolaas E P, Wierzchowska-McNew Raven A, Ruebush Laura E, Engelen Mariëlle P K J. Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.. American journal of hypertension. 2026. DOI: 10.1093/ajh/hpag047.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.